http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006013871-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ef589234f465a702a93350f2e499275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9dc12a886639e573e235a17fec6d07bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bdbc9dc7927a86b90761a765489012a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d66b97013dad04b7936f58b6743984d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77c8d669a090795a35bbbdb0ee47bc28
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
filingDate 2005-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6f1dd27c51e6c310bcc6bef1dcdbc67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11f4db2072e9a5b6557d892367c8df11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3559b174c666cdf2931c3fc0b5a1f553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_154c05d2073e9302055a319c1c7e59d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e65710839b69b828ea5fed9665abd88e
publicationDate 2006-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2006013871-A1
titleOfInvention Intimate coating of ibuprofen with poloxamers to enhance aqueous dissolution
abstract This invention provides methods for enhancing the dissolution rate of Ibuprofen. More particularly, the invention provides a process for enhancing the solubility of Ibuprofen by intimately coating Ibuprofen particles with a Poloxamer. The invention also provides for a composition comprising a solid dosage form of Ibuprofen, wherein the surfaces of Ibuprofen particles have been intimately coated with a Poloxamer; a composition comprising a fast onset, solid dosage form of Ibuprofen; and a composition comprising Ibuprofen particles intimately coated with a Poloxamer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010087463-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9662345-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501760-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008057121-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014194872-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007187097-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293756-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014371166-A1
priorityDate 2003-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6013280-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004091529-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135736840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128597033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413480
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059199

Total number of triples: 63.